Alessandro Padovani to Brain
This is a "connection" page, showing publications Alessandro Padovani has written about Brain.
Connection Strength
0.595
-
The brain in late-onset glycogenosis II: a structural and functional MRI study. J Inherit Metab Dis. 2013 Nov; 36(6):989-95.
Score: 0.149
-
Imaging of Neurologic Disease in Hospitalized Patients with COVID-19: An Italian Multicenter Retrospective Observational Study. Radiology. 2020 11; 297(2):E270-E273.
Score: 0.061
-
The role of clinical and neuroimaging features in the diagnosis of CADASIL. J Neurol. 2018 Dec; 265(12):2934-2943.
Score: 0.054
-
Modulation of long-term potentiation-like cortical plasticity in the healthy brain with low frequency-pulsed electromagnetic fields. BMC Neurosci. 2018 06 13; 19(1):34.
Score: 0.053
-
Short-term outcome of carotid dissecting pseudoaneurysm: is it always benign? Acta Neurol Belg. 2018 Dec; 118(4):537-539.
Score: 0.053
-
Biological, Neuroimaging, and Neurophysiological Markers in Frontotemporal Dementia: Three Faces of the Same Coin. J Alzheimers Dis. 2018; 62(3):1113-1123.
Score: 0.052
-
Neuroanatomical Correlates of Transcranial Magnetic Stimulation in Presymptomatic Granulin Mutation Carriers. Brain Topogr. 2018 05; 31(3):488-497.
Score: 0.051
-
Advances on biological markers in early diagnosis of Alzheimer disease. Adv Clin Chem. 2005; 39:107-29.
Score: 0.021
-
Comparison of visual criteria for amyloid-PET reading: could criteria merging reduce inter-rater variability? Q J Nucl Med Mol Imaging. 2020 Dec; 64(4):414-421.
Score: 0.014
-
The impact of transcranial magnetic stimulation on diagnostic confidence in patients with Alzheimer disease. Alzheimers Res Ther. 2018 09 18; 10(1):94.
Score: 0.014
-
Quantitative appraisal of the Amyloid Imaging Taskforce appropriate use criteria for amyloid-PET. Alzheimers Dement. 2018 08; 14(8):1088-1098.
Score: 0.013
-
Single-subject SPM FDG-PET patterns predict risk of dementia progression in Parkinson disease. Neurology. 2018 03 20; 90(12):e1029-e1037.
Score: 0.013
-
Autoimmunity and Frontotemporal Dementia. Curr Alzheimer Res. 2018; 15(7):602-609.
Score: 0.013
-
Docosahexaenoic acid is a beneficial replacement treatment for spinocerebellar ataxia 38. Ann Neurol. 2017 Oct; 82(4):615-621.
Score: 0.013
-
Frontotemporal Dementia due to the Novel GRN Arg161GlyfsX36 Mutation. J Alzheimers Dis. 2017; 57(4):1185-1189.
Score: 0.012
-
Cognitive reserve in granulin-related frontotemporal dementia: from preclinical to clinical stages. PLoS One. 2013; 8(9):e74762.
Score: 0.010